the US Food & Drug Administration therapeutics will need to meet quality standards like those required by conventional drugs. Although such novel treatments are gaining approval by Digital , another requirement is compliance with quality standards from United States Pharmacopeia (USP), which will be challenging. Purity determines if there is anything unexpected in the pill. The USP is looking to introduce standards that will enable doctors to confidently use the new treatments, said Novartis , CEO of USP. Novartis , head of digital therapeutics at Novartis , said early software testing could be likened to preclinical studies for drugs.
the US Food & Drug Administration therapeutics will need to meet quality standards like those required by conventional drugs. Although such novel treatments are gaining approval by Digital , another requirement is compliance with quality standards from United States Pharmacopeia (USP), which will be challenging. The USP is looking to introduce standards that will enable doctors to confidently use the new treatments, said Novartis , CEO of USP. Novartis , head of digital therapeutics at Novartis , said early software testing could be likened to preclinical studies for drugs.